First Trust Advisors’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-66,118
| Closed | -$2.01M | – | 2649 |
|
|
2022
Q2 | $2.01M | Sell |
66,118
-23,463
| -26% | -$635K | ﹤0.01% | 1714 |
|
|
2022
Q1 | $2.33M | Buy |
89,581
+18,549
| +26% | +$441K | ﹤0.01% | 1723 |
|
|
2021
Q4 | $1.45M | Buy |
71,032
+8,780
| +14% | +$168K | ﹤0.01% | 1920 |
|
|
2021
Q3 | $1.2M | Buy |
+62,252
| New | +$1.24M | ﹤0.01% | 1969 |
|
|
2021
Q2 | – | Sell |
-139,157
| Closed | -$3.65M | – | 2568 |
|
|
2021
Q1 | $3.65M | Buy |
139,157
+22,400
| +19% | +$533K | ﹤0.01% | 1432 |
|
|
2020
Q4 | $2.18M | Buy |
+116,757
| New | +$2.18M | ﹤0.01% | 1528 |
|
|
2020
Q3 | – | Sell |
-85,942
| Closed | -$2M | – | 2527 |
|
|
2020
Q2 | $2M | Buy |
85,942
+6,291
| +8% | +$91.2K | ﹤0.01% | 1377 |
|
|
2020
Q1 | $669K | Sell |
79,651
-15,448
| -16% | -$130K | ﹤0.01% | 1817 |
|
|
2019
Q4 | $929K | Sell |
95,099
-1,793
| -2% | -$16.8K | ﹤0.01% | 1911 |
|
|
2019
Q3 | $920K | Buy |
+96,892
| New | +$1.02M | ﹤0.01% | 1905 |
|
|
2018
Q3 | – | Sell |
-48,059
| Closed | -$764K | – | 2558 |
|
|
2018
Q2 | $764K | Buy |
48,059
+7,348
| +18% | +$110K | ﹤0.01% | 2028 |
|
|
2018
Q1 | $578K | Buy |
40,711
+2,933
| +8% | +$43.4K | ﹤0.01% | 1987 |
|
|
2017
Q4 | $529K | Buy |
37,778
+4,298
| +13% | +$62.9K | ﹤0.01% | 2072 |
|
|
2017
Q3 | $479K | Buy |
+33,480
| New | +$478K | ﹤0.01% | 2098 |
|
|
2017
Q1 | – | Sell |
-29,433
| Closed | -$521K | – | 2478 |
|
|
2016
Q4 | $521K | Buy |
29,433
+3,231
| +12% | +$56.8K | ﹤0.01% | 2110 |
|
|
2016
Q3 | $505K | Sell |
26,202
-18,913
| -42% | -$370K | ﹤0.01% | 1993 |
|
|
2016
Q2 | $880K | Sell |
45,115
-24,315
| -35% | -$477K | ﹤0.01% | 1764 |
|
|
2016
Q1 | $1.43M | Buy |
69,430
+28,886
| +71% | +$569K | ﹤0.01% | 1481 |
|
|
2015
Q4 | $832K | Buy |
40,544
+630
| +2% | +$12.1K | ﹤0.01% | 1802 |
|
|
2015
Q3 | $683K | Sell |
39,914
-261
| -0.6% | -$4.77K | ﹤0.01% | 1858 |
|
|
2015
Q2 | $749K | Sell |
40,175
-3,205
| -7% | -$59.4K | ﹤0.01% | 1863 |
|
|
2015
Q1 | $828K | Buy |
43,380
+13,369
| +45% | +$247K | ﹤0.01% | 1815 |
|
|
2014
Q4 | $494K | Sell |
30,011
-2,107
| -7% | -$36.1K | ﹤0.01% | 1983 |
|
|
2014
Q3 | $568K | Buy |
32,118
+4,979
| +18% | +$97.8K | ﹤0.01% | 1883 |
|
|
2014
Q2 | $560K | Buy |
+27,139
| New | +$558K | ﹤0.01% | 1874 |
|
|
2014
Q1 | – | Sell |
-19,492
| Closed | -$517K | – | 2331 |
|
|
2013
Q4 | $517K | Buy |
19,492
+9,256
| +90% | +$228K | ﹤0.01% | 1889 |
|
|
2013
Q3 | $242K | Buy |
+10,236
| New | +$239K | ﹤0.01% | 2158 |
|
Other funds holding VIVO
IC
MF
First Trust Advisors's VIVO Position: Q3 2022 in Review
First Trust Advisors sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 66,118 shares — an estimated $2.01M sold.
First Trust Advisors first reported a position in VIVO in Q3 2013 and held it in 27 quarters. The position peaked at $3.65M in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.
- First Trust Advisors reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
- First Trust Advisors sold 66,118 Meridian Bioscience Inc shares in Q3 2022, an estimated $2.01M.
- First Trust Advisors first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 27 quarters.
- First Trust Advisors's Meridian Bioscience Inc position peaked at $3.65M in Q1 2021.
- 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.
Based on First Trust Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.